NCT06308107View on ClinicalTrials.gov

Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

May 9, 2025

Study Completion Date

May 9, 2025

Conditions
Myocardial Stunning
Interventions
DRUG

IV Diazoxide

500 micromoles added to one liter of cardioplegia

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

Magic That Matters

UNKNOWN

lead

Johns Hopkins University

OTHER

NCT06308107 - Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) Trial | Biotech Hunter | Biotech Hunter